INCRELINS

Welcome to the Brand page for “INCRELINS”, which is offered here for Biomedical compounds, synthetic peptides designed to control blood glucose levels for industrial, laboratory, research, and medical laboratory or research use;.

Its status is currently believed to be active. Its class is unavailable. “INCRELINS” is believed to be currently owned by “Calibrium, LLC”.

Owner:
CALIBRIUM, LLC
Owner Details
Description:
Biomedical compounds, synthetic peptides designed to control blood glucose levels for industrial, laboratory, research, and medical laboratory or research use;
Categories: BIOMEDICAL COMPOUNDS